{
    "id": 1013,
    "fullName": "MET Y1248H",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MET Y1248H (corresponds to Y1230H in the canonical isoform) lies within the protein kinase domain and RANBP9-interacting region of the Met protein (UniProt.org). Y1248H results in constitutive Met phosphorylation, is transforming in cell culture, and promotes tumor formation in mice (PMID: 15064724, PMID: 9326629).",
            "references": [
                {
                    "id": 2199,
                    "pubMedId": 9326629,
                    "title": "Activating mutations for the met tyrosine kinase receptor in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9326629"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 452,
                    "pubMedId": 15064724,
                    "title": "The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15064724"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "Y1248H",
    "createDate": "07/16/2014",
    "updateDate": "07/31/2019",
    "referenceTranscriptCoordinates": {
        "id": 144984,
        "transcript": "NM_001127500",
        "gDna": "chr7:g.116783359T>C",
        "cDna": "c.3742T>C",
        "protein": "p.Y1248H",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 812,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a cell line expressing MET Y1248H showed resistance to SU11274 treatment (PMID: 15064724).",
            "molecularProfile": {
                "id": 1122,
                "profileName": "MET Y1248H"
            },
            "therapy": {
                "id": 1089,
                "therapyName": "SU11274",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "resistant",
            "references": [
                {
                    "id": 452,
                    "pubMedId": 15064724,
                    "title": "The Met kinase inhibitor SU11274 exhibits a selective inhibition pattern toward different receptor mutated variants.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/15064724"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1122,
            "profileName": "MET Y1248H",
            "profileTreatmentApproaches": [
                {
                    "id": 7894,
                    "name": "MET Inhibitor",
                    "profileName": "MET Y1248H"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144984,
            "transcript": "NM_001127500",
            "gDna": "chr7:g.116783359T>C",
            "cDna": "c.3742T>C",
            "protein": "p.Y1248H",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}